Zacks Investment ResearchMon, 11 May 2026 16:51:06 GMTRCKT Stock Down on Q1 Earnings Miss, Kresladi Launch in FocusRCKT-1.10%
Zacks Investment ResearchMon, 30 Mar 2026 17:21:12 GMTRCKT Stock Down Despite FDA Nod to Gene Therapy in Rare DiseaseRCKT-1.10%
Seeking AlphaFri, 27 Mar 2026 18:45:55 GMTRocket Pharmaceuticals, Inc. (RCKT) Discusses FDA Approval of KRESLADI Gene Therapy for Severe Leukocyte Adhesion Deficiency Type 1 TranscriptRCKT-1.10%
Seeking AlphaFri, 06 Mar 2026 18:56:05 GMTRocket Pharmaceuticals, Inc. (RCKT) Presents at TD Cowen 46th Annual Health Care Conference TranscriptRCKT-1.10%
Zacks Investment ResearchFri, 27 Feb 2026 18:50:19 GMTRCKT's Q4 Loss Narrower Than Estimated, Pipeline in FocusRCKT-1.10%
